The global cell surface marker detection market is expected to reach USD 6.49 billion by 2022, according to a new report by Grand View Research, Inc. This growth in demand can be attributed to rise in incidence of oncology diseases and other cell-associated disorders.
Rapid
introduction of advancements and automations in clinical laboratories is a key factor
affecting this industry. Incorporation of novel algorithms pertaining to
diagnosis and prognosis of chronic disorders is expected to fuel demand of this
market in the coming years.
Requirement
of solutions for data handling and interpretation of clinical conditions based
on obtained results are anticipated to enhance potential for R&D in this
sector, consequently driving market growth over the forecast period.
For Full Research Report On Cell Surface Marker Detection Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/cell-surface-marker-detection-market
Further key
findings from the report suggest:
- Flow cytometry devices
accounted for over 70% of the revenue generated in the industry for 2014.
This large share can be attributed to the growing advancement in these
instruments such as enhancement in efficiency and resolution of
fluorescence-based cytometric detectors. Furthermore, presence of large
product portfolio of different industry players operating in cytometry is
responsible for large market share of this technique.
- Disease diagnosis and
identification accounted for over 50% of the revenue generated in the
market for 2014. High incidence rate of cell-associated disorders and
oncology diseases that need to be treated in order to curb the mortality
rate are the major drivers for growth of this segment.
- Determination of novel drug
targets and development of biopharmaceuticals for prognosis of chronic
diseases is anticipated to propel growth of research and drug discovery
sub-segment in the coming years. With expected development of this
segment, the sector will witness lucrative growth over the forecast
period.
- North America accounted for
the largest share of this sector for 2014, as there are is significantly
high number of research and development projects ongoing in the region
related to cytological investigation for proteomics, genomics, and drug
and vaccine development. Growing need for biopharmaceuticals is also
anticipated to fuel regional growth.
- North America dominated the
industry in 2014, with revenue estimated at USD 999.0 million. Presence of
sophisticated healthcare infrastructure and favorable government
initiatives with respect to analytical techniques and their applications
for disease diagnosis and drug development are some key factors likely to
drive growth.
- Asia Pacific is expected to
witness lucrative growth from 2015 to 2022 due to the presence of
high-unmet medical needs coupled with rapidly rising healthcare R&D
investment and growing medical expenditures in emerging economies of India
and China
- Key participants of the cell
surface marker detection industry include Siemens Healthcare, Nihon Kohden
Corporation, Sartorius, Janssen Diagnostics Inc., Grifols SA, Thermo
Fisher Scientific, BioRad Laboratories Inc., and F. Hoffman La Roche
Ltd.
- These participants are
involved in R&D for production of cell-specific antibodies and
collaborations with smaller entities operating in the market as well as
with academic research laboratories in order to maintain their market
position and enter the untapped market regions
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/cell-surface-marker-detection-market/request/rs1
Grand View Research has segmented
cell surface marker detection market on the basis of product, application, and
region:
Cell Surface Marker
Detection Product Outlook (Market Revenue in USD Million, 2012 - 2022 )
- Flow Cytometry
- Hematology Analyzers
- Reagents & Kits
Cell Surface Marker
Detection Application Outlook (Market Revenue in USD Million, 2012 - 2022 )
- Disease Diagnosis &
Identification
- Research & Drug
Discovery
- Others
Cell Surface Marker
Detection Regional Outlook (Market Revenue in USD Million, 2012 - 2022 )
- North America
- Europe
- Asia Pacific
- RoW
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment